Ya Sheng Wang
Corporate Officer/Principal chez Jiangsu Vanguard Pharmaceutical Co., Ltd.
Profil
Ya Sheng Wang is currently the Deputy General Manager at Jiangsu Vanguard Pharmaceutical Co., Ltd.
He started this position in 2019.
Prior to his current role, he obtained an undergraduate degree from China Pharmaceutical University.
Postes actifs de Ya Sheng Wang
Sociétés | Poste | Début |
---|---|---|
Jiangsu Vanguard Pharmaceutical Co., Ltd.
Jiangsu Vanguard Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Jiangsu Vanguard Pharmaceutical Co., Ltd. engages in the research, development, production and sale of chemical drugs and proprietary Chinese medicines. Its products include valsartan hydrochlorothiazide tablets, calcium dobesilate capsules, calcium carbonate D3 chewable tablets, irbesartan hydrochlorothiazide tablets, bezafibrate dispersible tablets, aluminum magnesium carbonate chewable tablets, amlodipine maleate dispersible tablets, brucei seed oil soft capsules. The company was founded by Guang Xue He on November 28, 2003 and is headquartered in Nantong, China. | Corporate Officer/Principal | 01/05/2016 |
Formation de Ya Sheng Wang
China Pharmaceutical University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
Jiangsu Vanguard Pharmaceutical Co., Ltd.
Jiangsu Vanguard Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Jiangsu Vanguard Pharmaceutical Co., Ltd. engages in the research, development, production and sale of chemical drugs and proprietary Chinese medicines. Its products include valsartan hydrochlorothiazide tablets, calcium dobesilate capsules, calcium carbonate D3 chewable tablets, irbesartan hydrochlorothiazide tablets, bezafibrate dispersible tablets, aluminum magnesium carbonate chewable tablets, amlodipine maleate dispersible tablets, brucei seed oil soft capsules. The company was founded by Guang Xue He on November 28, 2003 and is headquartered in Nantong, China. | Health Technology |